SMAIO SA is engaged in offering spine surgeons a complete solution, consisting of software, implantable devices, and associated services, to treat spinal pathologies requiring surgery.
n/a
LTM Revenue $10.5M
LTM EBITDA -$1.1M
$44.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of September 2025, SMAIO reported last 12-month revenue of $10.5M and EBITDA of -$1.1M.
In the same period, SMAIO achieved -$1.9M in LTM net income.
See SMAIO valuation multiples based on analyst estimatesIn the most recent fiscal year, SMAIO reported revenue of $6.6M and EBITDA of -$40K.
SMAIO expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See SMAIO valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $10.5M | XXX | $6.6M | XXX | XXX | XXX |
Gross Profit | n/a | XXX | $3.9M | XXX | XXX | XXX |
Gross Margin | n/a | XXX | 58% | XXX | XXX | XXX |
EBITDA | -$1.1M | XXX | -$40K | XXX | XXX | XXX |
EBITDA Margin | -10% | XXX | -1% | XXX | XXX | XXX |
EBIT | -$2.7M | XXX | -$1.7M | XXX | XXX | XXX |
EBIT Margin | -26% | XXX | -26% | XXX | XXX | XXX |
Net Profit | -$1.9M | XXX | -$1.1M | XXX | XXX | XXX |
Net Margin | -18% | XXX | -16% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SMAIO has current market cap of EUR 39.4M (or $45.5M), and EV of EUR 38.5M (or $44.5M).
As of October 17, 2025, SMAIO's stock price is EUR 7 (or $8).
See SMAIO trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$44.5M | $45.5M | XXX | XXX | XXX | XXX | $-0.34 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialSMAIO's trades at 6.7x EV/Revenue multiple, and -1118.6x EV/EBITDA.
See valuation multiples for SMAIO and 15K+ public compsAs of October 17, 2025, SMAIO has market cap of $45.5M and EV of $44.5M.
Equity research analysts estimate SMAIO's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SMAIO has a P/E ratio of -23.7x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $45.5M | XXX | $45.5M | XXX | XXX | XXX |
EV (current) | $44.5M | XXX | $44.5M | XXX | XXX | XXX |
EV/Revenue | 4.2x | XXX | 6.7x | XXX | XXX | XXX |
EV/EBITDA | -41.8x | XXX | -1118.6x | XXX | XXX | XXX |
EV/EBIT | -16.3x | XXX | -25.6x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | -23.7x | XXX | -42.2x | XXX | XXX | XXX |
EV/FCF | -13.4x | XXX | -12.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSMAIO's last 12 month revenue growth is 48%
SMAIO's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
SMAIO's rule of 40 is 75% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SMAIO's rule of X is 110% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for SMAIO and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 48% | XXX | 58% | XXX | XXX | XXX |
EBITDA Margin | -10% | XXX | -1% | XXX | XXX | XXX |
EBITDA Growth | -176% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | 75% | XXX | 48% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 110% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 85% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Apiam Animal Health | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
Artrya | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SMAIO acquired XXX companies to date.
Last acquisition by SMAIO was XXXXXXXX, XXXXX XXXXX XXXXXX . SMAIO acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhere is SMAIO headquartered? | SMAIO is headquartered in France. |
Is SMAIO publicy listed? | Yes, SMAIO is a public company listed on PAR. |
What is the stock symbol of SMAIO? | SMAIO trades under ALSMA ticker. |
When did SMAIO go public? | SMAIO went public in 2022. |
Who are competitors of SMAIO? | Similar companies to SMAIO include e.g. Apiam Animal Health, Alcidion Group, Artrya, CurveBeam AI. |
What is the current market cap of SMAIO? | SMAIO's current market cap is $45.5M |
What is the current revenue of SMAIO? | SMAIO's last 12 months revenue is $10.5M. |
What is the current revenue growth of SMAIO? | SMAIO revenue growth (NTM/LTM) is 48%. |
What is the current EV/Revenue multiple of SMAIO? | Current revenue multiple of SMAIO is 4.2x. |
Is SMAIO profitable? | Yes, SMAIO is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of SMAIO? | SMAIO's last 12 months EBITDA is -$1.1M. |
What is SMAIO's EBITDA margin? | SMAIO's last 12 months EBITDA margin is -10%. |
What is the current EV/EBITDA multiple of SMAIO? | Current EBITDA multiple of SMAIO is -41.8x. |
What is the current FCF of SMAIO? | SMAIO's last 12 months FCF is -$3.3M. |
What is SMAIO's FCF margin? | SMAIO's last 12 months FCF margin is -32%. |
What is the current EV/FCF multiple of SMAIO? | Current FCF multiple of SMAIO is -13.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.